跳至主要内容
临床试验/NCT03350802
NCT03350802已完成不适用

Usefulness of Procalcitonin Test to Differentiate the Cause of Pneumonia in Patients With Cancers

National Cancer Center, Korea1 个研究点 分布在 1 个国家目标入组 649 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
649
试验地点
1
主要终点
Procalcitonin level according to the cause of pneumonia in patients with cancer

研究概览

简要总结

The purpose of this study is to evaluate the usefulness of procalcitonin test for differentiation of the cause of pneumonia in patients with cancer.

详细描述

Serum procalcitonin test is currently used as the biomarker for bacterial infection. Especially, procalcitonin test has been reported to be helpful in differentiating bacterial pneumonia from viral pneumonia, acute exacerbations of interstitial pneumonitis or chronic obstructive lung disease. However, it is not known whether procalcitonin test can help distinguish bacterial pneumonia from non-bacterial pneumonia such as radiation pneumonitis or chemotherapy-induced pneumonitis in patients with cancer.

The aim of this prospective cohort study is to observe the clinical benefits of procalcitonin test for differentiation of the cause of pneumonia in patients with cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than 18 years
  • Patients who have symptoms and suspected imaging findings compatible with pneumonia

排除标准

  • Patients who have been treated with antibiotics or steroid therapy.

结局指标

主要结局

Procalcitonin level according to the cause of pneumonia in patients with cancer

时间窗: procalcitonin level is checked within 24hours after visiting hospital

bacterial pneumonia vs. radiation pneumonitis vs chemotherapy-induced pneumonitis

次要结局

  • Influence of neutropenia on procalcitonin level in patients with baterial pneumonia(procalcitonin level is checked within 24hours after visiting hospital)
  • procalcitonin level in patients with atypical pneumonia(procalcitonin level is checked within 24hours after visiting hospital)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Hee Seok Lee

Pulmonologist

National Cancer Center, Korea

研究点 (1)

Loading locations...

相似试验